nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A novel in vivo predictive dissolution testing coupled with a modeling and simulation for hydrogel matrix monolithic extended release oral dosage forms
|
Kambayashi, Atsushi |
|
|
138 |
C |
p. |
artikel |
2 |
Antioxidant properties of probucol released from mesoporous silica
|
Lau, Michael |
|
|
138 |
C |
p. |
artikel |
3 |
A systems pharmacokinetic/pharmacodynamic model for concizumab to explore the potential of anti-TFPI recycling antibodies
|
Yuan, Dongfen |
|
|
138 |
C |
p. |
artikel |
4 |
Biosensor-based kinetic and thermodynamic characterization of opioids interaction with human μ-opioid receptor
|
Babazada, Hasan |
|
|
138 |
C |
p. |
artikel |
5 |
BRD4 PROTAC as a novel therapeutic approach for the treatment of vemurafenib resistant melanoma: Preformulation studies, formulation development and in vitro evaluation
|
Rathod, Drishti |
|
|
138 |
C |
p. |
artikel |
6 |
Combining biorelevant in vitro and in silico tools to simulate and better understand the in vivo performance of a nano-sized formulation of aprepitant in the fasted and fed states
|
Litou, Chara |
|
|
138 |
C |
p. |
artikel |
7 |
Comparison of liquid chromatography-mass spectrometry and direct infusion microchip electrospray ionization mass spectrometry in global metabolomics of cell samples
|
Pöhö, Päivi |
|
|
138 |
C |
p. |
artikel |
8 |
Design, synthesis, biological evaluation and molecular docking study of arylcarboxamido piperidine and piperazine-based hydroxamates as potential HDAC8 inhibitors with promising anticancer activity
|
Trivedi, Prakruti |
|
|
138 |
C |
p. |
artikel |
9 |
Development and optimization of a novel PLGA-Levan based drug delivery system for curcumin, using a quality-by-design approach
|
Bahadori, Fatemeh |
|
|
138 |
C |
p. |
artikel |
10 |
Editorial Board
|
|
|
|
138 |
C |
p. |
artikel |
11 |
Enhancing the physical stability and supersaturation generation of amorphous drug-polyelectrolyte nanoparticle complex via incorporation of crystallization inhibitor at the nanoparticle formation step: A case of HPMC versus PVP
|
Dong, Bingxue |
|
|
138 |
C |
p. |
artikel |
12 |
Enteric coating of oral solid dosage forms as a tool to improve drug bioavailability
|
Maderuelo, Cristina |
|
|
138 |
C |
p. |
artikel |
13 |
Improvement of antimalarial activity of a 3-alkylpiridine alkaloid analog by replacing the pyridine ring to a thiazole-containing heterocycle: Mode of action, mutagenicity profile, and Caco-2 cell-based permeability
|
Guimarães, Daniel Silqueira Martins |
|
|
138 |
C |
p. |
artikel |
14 |
Inhibitory effects of selected antibiotics on the activities of α-amylase and α-glucosidase: In-vitro, in-vivo and theoretical studies
|
Amiri, Bita |
|
|
138 |
C |
p. |
artikel |
15 |
Interpreting non-linear drug diffusion data: Utilizing Korsmeyer-Peppas model to study drug release from liposomes
|
Wu, Iren Yeeling |
|
|
138 |
C |
p. |
artikel |
16 |
Investigation of the permeation enhancer strategy on benzoylaconitine transdermal patch: the relationship between transdermal enhancement strength and physicochemical properties of permeation enhancer
|
Liu, Chao |
|
|
138 |
C |
p. |
artikel |
17 |
In vitro activity, ultrastructural studies and in silico pharmacokinetic properties of indol-3-yl-thiosemicarbazones derivatives and analogues against juvenile and adult worms of S. mansoni
|
de Almeida Júnior, Antônio Sérgio Alves |
|
|
138 |
C |
p. |
artikel |
18 |
NLG919/cyclodextrin complexation and anti-cancer therapeutic benefit as a potential immunotherapy in combination with paclitaxel
|
Xu, Jian |
|
|
138 |
C |
p. |
artikel |
19 |
Optimization of a paediatric fixed dose combination mini-tablet and dosing regimen for the first line treatment of tuberculosis
|
Tsiligiannis, Alexios |
|
|
138 |
C |
p. |
artikel |
20 |
Pemetrexed-conjugated hyaluronan for the treatment of malignant pleural mesothelioma
|
Amano, Yuki |
|
|
138 |
C |
p. |
artikel |
21 |
Pharmacokinetics and hemorheology of phosphocreatine and creatine in rabbits: A directly comparative study between parent drug and active metabolite
|
Xi, Heng |
|
|
138 |
C |
p. |
artikel |
22 |
Pore change during degradation of octreotide acetate-loaded PLGA microspheres: The effect of polymer blends
|
Wang, Tengteng |
|
|
138 |
C |
p. |
artikel |
23 |
Preparation of a nanoscale dihydromyricetin-phospholipid complex to improve the bioavailability: in vitro and in vivo evaluations
|
Zhao, Xinyuan |
|
|
138 |
C |
p. |
artikel |
24 |
Self microemulsifying drug delivery system of lurasidone hydrochloride for enhanced oral bioavailability by lymphatic targeting: In vitro, Caco-2 cell line and in vivo evaluation
|
Patel, Mitali H. |
|
|
138 |
C |
p. |
artikel |
25 |
Sulfocoumarins, specific carbonic anhydrase IX and XII inhibitors, interact with cancer multidrug resistant phenotype through pH regulation and reverse P-glycoprotein mediated resistance
|
Podolski-Renić, Ana |
|
|
138 |
C |
p. |
artikel |
26 |
Sustained-release microparticle dry powders of chloramphenicol palmitate or thiamphenicol palmitate prodrugs for lung delivery as aerosols
|
Nurbaeti, Siti Nani |
|
|
138 |
C |
p. |
artikel |
27 |
Tannic acid as a precipitating agent of human plasma proteins
|
Pinto, Aline Ferreira |
|
|
138 |
C |
p. |
artikel |
28 |
Target-mediated disposition population pharmacokinetics model of erythropoietin in premature neonates following multiple intravenous and subcutaneous dosing regimens
|
D'Cunha, Ronilda |
|
|
138 |
C |
p. |
artikel |